NovoCure (NVCR) Accounts Payables (2014 - 2026)
NovoCure (NVCR) posted Accounts Payables of $130.7 million for Q2 2026, up 2.74% sequentially from $127.2 million in Q1 2026, and up 26.09% YoY from $103.7 million in Q2 2025.
NovoCure (NVCR) Accounts Payables (2014 - 2026) Analysis & Trends
NovoCure has reported Accounts Payables for 13 years, with the latest figure at $130.7 million in Q2 2026.
- Quarterly Accounts Payables rose 26.09% year-over-year to $130.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $130.7 million (up 26.09% YoY) and the FY2025 annual result came in at $122.2 million, up 16.32% from the prior year.
- Accounts Payables rose to $130.7 million in Q2 2026 per NVCR's latest filing, from $127.2 million in the prior quarter.
- Over five years, Accounts Payables peaked at $130.7 million in Q2 2026 and troughed at $69.2 million in Q1 2022.
- A 5-year average of $95.5 million and a median of $90.7 million in 2024 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2022 and 2023: Accounts Payables jumped 40.72% in 2022, then rose 3.29% in 2023.
- Over 5 years, Accounts Payables stood at $85.2 million in 2022, then increased by 10.79% to $94.4 million in 2023, then grew by 11.33% to $105.1 million in 2024, then gained by 16.32% to $122.2 million in 2025, then increased by 6.95% to $130.7 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $130.7 million, $127.2 million, and $122.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 4.79 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.23 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 210.50 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 3.23 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 2.42 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 344.10 Mn |
| 10 | NovoCure | 2.06 Bn | 1.62 Bn | 142.48 Mn | 130.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 130.73 Mn |
| Mar 31, 2026 | 127.24 Mn |
| Dec 31, 2025 | 122.23 Mn |
| Sep 30, 2025 | 118.92 Mn |
| Jun 30, 2025 | 103.68 Mn |
| Mar 31, 2025 | 95.09 Mn |
| Dec 31, 2024 | 105.09 Mn |
| Sep 30, 2024 | 91.32 Mn |
| Jun 30, 2024 | 90.17 Mn |
| Mar 31, 2024 | 84.32 Mn |
| Dec 31, 2023 | 94.39 Mn |
| Sep 30, 2023 | 79.67 Mn |
| Jun 30, 2023 | 82.54 Mn |
| Mar 31, 2023 | 81.47 Mn |
| Dec 31, 2022 | 85.20 Mn |
| Sep 30, 2022 | 77.03 Mn |
| Jun 30, 2022 | 79.91 Mn |
| Mar 31, 2022 | 69.19 Mn |
| Dec 31, 2021 | 72.60 Mn |
| Sep 30, 2021 | 60.01 Mn |